PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 80 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,033 | -14.8% | 12,250 | +17.6% | 0.00% | – |
| Q2 2023 | $149,157 | +33.6% | 10,416 | +3.3% | 0.00% | – |
| Q3 2022 | $111,686 | +26.2% | 10,080 | -3.9% | 0.00% | – |
| Q2 2022 | $88,485 | -60.7% | 10,484 | -8.4% | 0.00% | – |
| Q4 2021 | $225,000 | -37.3% | 11,443 | +2.3% | 0.00% | – |
| Q3 2021 | $359,000 | -10.7% | 11,190 | -5.9% | 0.00% | – |
| Q2 2021 | $402,000 | +50.0% | 11,889 | +66.9% | 0.00% | – |
| Q1 2021 | $268,000 | +17.5% | 7,124 | +3.9% | 0.00% | – |
| Q4 2020 | $228,000 | -7.7% | 6,857 | +1.7% | 0.00% | – |
| Q3 2020 | $247,000 | +8.8% | 6,744 | 0.0% | 0.00% | – |
| Q2 2020 | $227,000 | – | 6,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |